Previous / Next

[20111211. Bleeding peptic ulcer (23): Pharmacologic treatment (1) - consensus recommendation]

ÃâÇ÷¼º ¼ÒÈ­¼º ±Ë¾çÀÇ ¾à¹°Ä¡·á¿¡ ´ëÇؼ­´Â 2010³â consensus report¸¦ Âü°íÇÏ´Â °ÍÀÌ ÁÁ´Ù (Ann Intern Med 2010;152:101-113). ÇØ´ç ºÎºÐÀ» ¿Å±â¸é ¾Æ·¡¿Í °°´Ù.

C1. Histamine-2 receptor antagonists are not recommended for patients with acute ulcer bleeding.

C2. Somatostatin and octreotide are not routinely recommended for patients with acute ulcer bleeding.

C3. An intravenous bolus followed by continuous-infusion PPI therapy should be used to decrease rebleeding and mortality in patients with high-risk stigmata who have undergone successful endoscopic therapy.

C4. Patients should be discharged with a prescription for a single daily-dose oral PPI for a duration as dictated by the underlying etiology.


Å©°Ô º¸½Ã·Á¸é ±×¸²À» Ŭ¸¯Çϼ¼¿ä.


[New York Times] À§»êÀ» ¹ß°ßÇÑ ÀÇ»ç À̾߱â

¼ÒÈ­¼º±Ë¾ç ¾àÁ¦ Á¤º¸ - ±¹¸³¾Ï¼¾ÅÍ ¾àÁ¦ºÎ (2013³â, ¿ÜºÎ PDF ¸µÅ©)

[Home]